Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature.
- DOI
- 10.21037/tlcr-22-394
- Published
- 2022 Jun
- Container
- Translational lung cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-22-394,
title = {Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature.},
author = {Lei X and Zhu S and Ren D and Ren F and Li T and Zhou N and Li S and Shi T and Zu L and Song Z and Chalubinska-Fendler J and Denis MG and Bernicker EH and Thomas de Montpréville V and Jiang R and Xu S},
year = {2022},
journal = {Translational lung cancer research},
doi = {10.21037/tlcr-22-394},
url = {https://doi.org/10.21037/tlcr-22-394}
}RIS
TY - JOUR TI - Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature. AU - Lei X AU - Zhu S AU - Ren D AU - Ren F AU - Li T AU - Zhou N AU - Li S AU - Shi T AU - Zu L AU - Song Z AU - Chalubinska-Fendler J AU - Denis MG AU - Bernicker EH AU - Thomas de Montpréville V AU - Jiang R AU - Xu S PY - 2022 JO - Translational lung cancer research DO - 10.21037/tlcr-22-394 UR - https://doi.org/10.21037/tlcr-22-394 ER -
APA
X, L., S, Z., D, R., F, R., T, L., N, Z., S, L., T, S., L, Z., Z, S., J, C., MG, D., EH, B., V, T. D. M., R, J., & S, X. (2022). Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature.. Translational lung cancer research. https://doi.org/10.21037/tlcr-22-394
Source records
- pubmed · retrieved 2026-09-27T13:09:40.741Z